These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 8999609)
21. AIDS vaccine: efficacy, safety and ethics. Veljkovic V; Veljkovic N; Glisic S; Ho MW Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521 [TBL] [Abstract][Full Text] [Related]
22. Clinical research. A setback and an advance on the AIDS vaccine front. Cohen J Science; 2003 Apr; 300(5616):28-9. PubMed ID: 12677027 [No Abstract] [Full Text] [Related]
23. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor. Cohen J Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780 [No Abstract] [Full Text] [Related]
24. The private demand for an AIDS vaccine in Thailand. Suraratdecha C; Ainsworth M; Tangcharoensathien V; Whittington D Health Policy; 2005 Mar; 71(3):271-87. PubMed ID: 15694496 [TBL] [Abstract][Full Text] [Related]
25. AIDS vaccines: on the trail of two trials. Moore JP Nature; 2002 Jan; 415(6870):365-6. PubMed ID: 11807523 [No Abstract] [Full Text] [Related]
28. Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women. Johnson DC; McFarland EJ; Muresan P; Fenton T; McNamara J; Read JS; Hawkins E; Bouquin PL; Estep SG; Tomaras GD; Vincent CA; Rathore M; Melvin AJ; Gurunathan S; Lambert J J Infect Dis; 2005 Dec; 192(12):2129-33. PubMed ID: 16288378 [TBL] [Abstract][Full Text] [Related]
29. Advocacy group sees little progress toward an HIV vaccine. AIDS Policy Law; 1998 May; 13(10):1, 8-9. PubMed ID: 11365444 [TBL] [Abstract][Full Text] [Related]
30. Toward oligosaccharide- and glycopeptide-based HIV vaccines. Wang LX Curr Opin Drug Discov Devel; 2006 Mar; 9(2):194-206. PubMed ID: 16566290 [TBL] [Abstract][Full Text] [Related]
31. An HIV vaccine: as we build it, will they come? McCluskey MM; Alexander SB; Larkin BD; Murguia M; Wakefield S Health Aff (Millwood); 2005; 24(3):643-51. PubMed ID: 15886155 [TBL] [Abstract][Full Text] [Related]
32. Willingness to participate in HIV vaccine research in a peri-urban South African community. Smit J; Middelkoop K; Myer L; Seedat S; Bekker LG; Stein DJ Int J STD AIDS; 2006 Mar; 17(3):176-9. PubMed ID: 16510005 [TBL] [Abstract][Full Text] [Related]
33. Design and construction of a recombinant epitope-peptide gene as a universal epitope-vaccine strategy. Liu Z; Chen YH J Immunol Methods; 2004 Feb; 285(1):93-7. PubMed ID: 14871538 [TBL] [Abstract][Full Text] [Related]
34. New vaccines. Stanley PJ; Ellis CJ Br J Hosp Med; 1989 Apr; 41(4):364-7. PubMed ID: 2655801 [TBL] [Abstract][Full Text] [Related]
35. [Vaccines against HIV]. Holm-Hansen C Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3117-20. PubMed ID: 17160118 [TBL] [Abstract][Full Text] [Related]
36. HIV vaccines 1983-2003. McMichael AJ; Hanke T Nat Med; 2003 Jul; 9(7):874-80. PubMed ID: 12835708 [TBL] [Abstract][Full Text] [Related]
37. A review of vaccine research and development: the human immunodeficiency virus (HIV). Girard MP; Osmanov SK; Kieny MP Vaccine; 2006 May; 24(19):4062-81. PubMed ID: 16530298 [TBL] [Abstract][Full Text] [Related]
38. [Betting on the International AIDS Vaccine Initiative: an anti-AIDS vaccine in 10 years]. Manus JM Rev Infirm; 1999 Oct; (53):11. PubMed ID: 10797793 [No Abstract] [Full Text] [Related]
39. [A vaccine against HIV--status after ten years of research]. Schønning K; Hansen JE Ugeskr Laeger; 1996 Dec; 158(49):7047-50. PubMed ID: 8999609 [No Abstract] [Full Text] [Related]